| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
183,678,000 |
| Market
Cap: |
4.34(B) |
| Last
Volume: |
775,760 |
Avg
Vol: |
773,642 |
| 52
Week Range: |
$23.21 - $33.63 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Delivery |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 581 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Alkermes is a biopharmaceutical company. Co. has a portfolio of marketed products focused on central nervous system disorders such as addiction and schizophrenia and a pipeline of product candidates in the fields of neuroscience and oncology. Co.'s proprietary products include: ARISTADA, which is an extended-release intramuscular injectable suspension approved in the U.S. for the treatment of schizophrenia; ARISTADA INITIO, which is indicated for the initiation of ARISTADA when used for the treatment of schizophrenia in adults; and VIVITROL, which is for the treatment of alcohol dependence and for the prevention of relapse to opioid dependence, following opioid detoxification.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
35,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$815,735 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
10,417 |
15,666 |
21,104 |
96,962 |
| Total Sell Value |
$292,740 |
$454,291 |
$626,511 |
$2,911,362 |
| Total People Sold |
1 |
3 |
3 |
4 |
| Total Sell Transactions |
1 |
3 |
5 |
8 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Pops Richard F |
Director and CEO, Alkermes plc |
• • – |
2018-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,000 |
672,131 |
|
- |
|
| Stejbach Mark |
SVP/Chief Comm Off, Alks Inc |
• • – |
2018-03-03 |
4 |
D |
$60.05 |
$75,123 |
D/D |
(1,251) |
51,065 |
|
- |
|
| Stejbach Mark |
SVP/Chief Comm Off, Alks Inc |
• • – |
2018-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,813 |
52,316 |
|
- |
|
| Frates James M |
SVP, Alks Inc; CFO ALKS |
• • – |
2018-03-03 |
4 |
D |
$60.05 |
$61,791 |
D/D |
(1,029) |
84,340 |
|
- |
|
| Frates James M |
SVP, Alks Inc; CFO ALKS |
• • – |
2018-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,813 |
85,369 |
|
- |
|
| Biberstein Kathryn L |
EVP/CAO/CCO/CRO Alks Inc; |
• • – |
2018-03-03 |
4 |
D |
$60.05 |
$93,438 |
D/D |
(1,556) |
40,200 |
|
- |
|
| Biberstein Kathryn L |
EVP/CAO/CCO/CRO Alks Inc; |
• • – |
2018-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,500 |
41,756 |
|
- |
|
| Cooke Shane |
President, Alkermes plc |
• • – |
2018-03-03 |
4 |
D |
$60.05 |
$163,937 |
D/D |
(2,730) |
84,872 |
|
- |
|
| Cooke Shane |
President, Alkermes plc |
• • – |
2018-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,250 |
87,602 |
|
- |
|
| Gaffin David Joseph |
SVP, CLO, Alkermes, Inc. |
• • – |
2018-03-03 |
4 |
D |
$60.05 |
$22,158 |
D/D |
(369) |
36,363 |
|
- |
|
| Gaffin David Joseph |
SVP, CLO, Alkermes, Inc. |
• • – |
2018-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
36,732 |
|
- |
|
| Landine Michael J |
SVP, Corp Dev., Alkermes, Inc. |
• • – |
2018-03-03 |
4 |
D |
$60.05 |
$57,288 |
D/D |
(954) |
172,644 |
|
- |
|
| Landine Michael J |
SVP, Corp Dev., Alkermes, Inc. |
• • – |
2018-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,813 |
173,598 |
|
- |
|
| Brown Iain Michael |
SVP Finance & CAO, Alks Inc. |
• • – |
2018-03-01 |
4 |
D |
$57.41 |
$38,063 |
D/D |
(663) |
21,014 |
|
- |
|
| Brown Iain Michael |
SVP Finance & CAO, Alks Inc. |
• • – |
2018-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,250 |
21,677 |
|
- |
|
| Pops Richard F |
Director and CEO, Alkermes plc |
• • – |
2018-03-01 |
4 |
D |
$57.41 |
$446,592 |
D/D |
(7,779) |
659,131 |
|
- |
|
| Pops Richard F |
Director and CEO, Alkermes plc |
• • – |
2018-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,500 |
666,910 |
|
- |
|
| Stejbach Mark |
SVP/Chief Comm Off, Alks Inc |
• • – |
2018-03-01 |
4 |
D |
$57.41 |
$133,995 |
D/D |
(2,334) |
49,503 |
|
- |
|
| Stejbach Mark |
SVP/Chief Comm Off, Alks Inc |
• • – |
2018-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,250 |
51,837 |
|
- |
|
| Frates James M |
SVP, Alks Inc; CFO ALKS |
• • – |
2018-03-01 |
4 |
D |
$57.41 |
$76,126 |
D/D |
(1,326) |
82,556 |
|
- |
|
| Frates James M |
SVP, Alks Inc; CFO ALKS |
• • – |
2018-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,500 |
83,882 |
|
- |
|
| Biberstein Kathryn L |
EVP/CAO/CCO/CRO Alks Inc; |
• • – |
2018-03-01 |
4 |
D |
$57.41 |
$126,704 |
D/D |
(2,207) |
38,256 |
|
- |
|
| Biberstein Kathryn L |
EVP/CAO/CCO/CRO Alks Inc; |
• • – |
2018-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,750 |
40,463 |
|
- |
|
| Cooke Shane |
President, Alkermes plc |
• • – |
2018-03-01 |
4 |
D |
$57.41 |
$208,972 |
D/D |
(3,640) |
82,352 |
|
- |
|
| Cooke Shane |
President, Alkermes plc |
• • – |
2018-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,000 |
85,992 |
|
- |
|
1496 Records found
|
|
Page 26 of 60 |
|
|
0.41 (1.68%) 
